Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Evident Technologies Announces Issuance of Key Patent for Semiconductor Nanocrystals Made From III-V Materials

Abstract:
Evident Technologies, Inc. today announced the issuance of US Patent No. 7,399,429 covering the ability to make semiconductor nanocrystals from III-V materials, including indium galium phosphide. This newly issued patent represents a dramatic increase in the advancement of semiconductor materials science and augments the breadth of the company's intellectual property portfolio.

Evident Technologies Announces Issuance of Key Patent for Semiconductor Nanocrystals Made From III-V Materials

New York, NY | Posted on September 23rd, 2008

"The issuance of this key patent underscores the fact that Evident Technologies, Inc. remains a pioneer in the development of novel and proprietary semiconductor nanocrystals, and affords us broad protection in a rapidly growing segment of the market," stated Clint Ballinger Ph.D., CEO of Evident Technologies. "In response to a growing industry demand, our scientists have worked diligently over the past several years to develop new bright, stable III-V material systems."

Evident Technologies' broad array of semiconductor nanocrystal materials are already used in many industries around the world in products ranging from electronics to life science reagents. Companies and research institutes alike can benefit from this new, patented technology and continue the development of quantum dot applications from energy conversion to LEDs to life science.

"The unique spectral properties of these III-V quantum dot nanocrystals include absorption in the ultraviolet through the near-infrared range and emission in the near-infrared range, and are ideal for several applications within the life sciences," said Todd R. Nelson Ph.D., CEO of eBioscience, the worldwide, exclusive licensee of this technology within the life sciences industry. "We believe our customers will find that the products enabled by this technology will represent a significant advancement in multicolor applications, and will allow us to develop the next generation of eFluor in-vivo imaging reagents."

####

About Evident Technologies, Inc.
Founded in 2000, Evident Technologies develops and commercializes technology based on semiconductor nanocrystals. Evident is one of the first companies to commercialize products based on semiconductor nanotechnology and has launched commercial products in LED and lighting, military and life science markets.

About eBioscience Corporation

eBioscience provides innovative high quality reagents to academic and government researchers and pharmaceutical and biotech companies worldwide that empower the process of scientific discovery in the areas of cellular immunity and oncology. The company’s extensive portfolio of more than 8,000 leading edge cell analysis reagents and technologies, focused on flow cytometry and immunodetection, position our customers to be at the forefront of science. eBioscience is aligned with and responsive to the ever changing needs of its customers, making the company a preferred partner for scientific discovery.

Founded in 1999, eBioscience is headquartered in San Diego, California and conducts business in more than 70 countries around the world. For more information about eBioscience, visit the company's web site at www.eBioscience.com.

For more information, please click here

Contacts:
Schwartz Public Relations
Steven Wright-Mark
212-677-8700 ext. 29

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Cryo-electron microscopy achieves unprecedented resolution using new computational methods March 25th, 2017

Argon is not the 'dope' for metallic hydrogen March 24th, 2017

Promising results obtained with a new electrocatalyst that reduces the need for platinum: Researchers from Aalto University have succeeded in manufacturing electrocatalysts used for storing electric energy with one-hundredth of the amount of platinum that is usually needed March 24th, 2017

Artificial photosynthesis steps into the light: Rice University lab turns transition metals into practical catalyst for solar, other applications March 23rd, 2017

Chip Technology

Argon is not the 'dope' for metallic hydrogen March 24th, 2017

Scientists discover new 'boat' form of promising semiconductor: GeSe Uncommon form attenuates semiconductor's band gap size March 23rd, 2017

Pulverizing e-waste is green, clean -- and cold: Rice, Indian Institute researchers use cryo-mill to turn circuit boards into separated powders March 21st, 2017

Electro-optical switch transmits data at record-low temperatures: Operating at temperatures near absolute zero, switch could enable significantly faster data processing with lower power consumption March 20th, 2017

Announcements

Cryo-electron microscopy achieves unprecedented resolution using new computational methods March 25th, 2017

Argon is not the 'dope' for metallic hydrogen March 24th, 2017

Promising results obtained with a new electrocatalyst that reduces the need for platinum: Researchers from Aalto University have succeeded in manufacturing electrocatalysts used for storing electric energy with one-hundredth of the amount of platinum that is usually needed March 24th, 2017

Artificial photosynthesis steps into the light: Rice University lab turns transition metals into practical catalyst for solar, other applications March 23rd, 2017

Patents/IP/Tech Transfer/Licensing

Harris & Harris Group Issues Its Financial Statements as of December 31, 2016, Posts Its Annual Shareholder Letter, And Will Host a Conference Call for Shareholders on Friday, March 17, 2017 March 15th, 2017

Intertronics introduce new nanoparticle deagglomeration technology March 15th, 2017

Keystone Nano Announces The US FDA Has Awarded Orphan Drug Designation For Ceramides For The Treatment Of Liver Cancer November 8th, 2016

Leti to Tackle Tomorrow's Research Strategies with Stanford University’s SystemX Alliance: French R&D Center Is the First Research Institute to Join the Collaboration and Provides Bridges Between Academia and Industry, Leveraging Alliance’s Potential October 4th, 2016

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project